Juan Yang

Dr. Juan Yang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JYJuan Yang
Juan Yang
MWMeng Wang
Meng Wang
FZFengming Zhu
Fengming Zhu
JSJie Sun
Jie Sun
HXHuzi Xu
Huzi Xu
YYYing Yao
Ying Yao
Putative endothelial progenitor cells (pEPCs) have been confirmed to participate in alleviation of renal fibrosis in several ischaemic diseases. However, their mechanistic effect on renal fibrosis, which is characterized by vascular regression and further rarefaction-related pathology, remains unknown. To explore the effect and molecular mechanisms by which pEPCs act on unilateral ureteral obstruction (UUO)-induced renal fibrosis, we isolated pEPCs from murine bone marrow. In vivo, pEPCs (2 × 105 cells/day) and pEPC-MVs (microvesicles) were injected into UUO mice via the tail vein. In vitro, pEPCs were co-cultured with renal-derived pericytes. Pericyte-myofibroblast transition was evaluated using the myofibroblast marker α-smooth muscle actin (α-SMA) and pericyte marker platelet-derived growth factor receptor β (PDGFR-β). Exogenous supply of bone marrow-derived pEPCs attenuated renal fibrosis by decreasing pericyte-myofibroblast transition without significant vascular repair in the UUO model. Our results indicated that pEPCs regulated pericytes and their transition into myofibroblasts via pEPC-MVs. Co-culture of pericytes with pEPCs in vitro suggested that pEPCs inhibit transforming growth factor-β (TGF-β)-induced pericyte–myofibroblast transition via a paracrine pathway. pEPCs effectively attenuated UUO-induced renal fibrosis by inhibiting pericyte–myofibroblast transition via a paracrine pathway, without promoting vascular repair.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
MWMeng Wang
Meng Wang
HXHuzi Xu
Huzi Xu
YLYinzheng Li
Yinzheng Li
CCChujin Cao
Chujin Cao
HZHan Zhu
Han Zhu
RZRui Zeng
Rui Zeng
Rationale: Capillaries are composed of endothelial cells and the surrounding mural cells, pericytes. Microvascular repair after injury involves not only the proliferation of endothelial cells but also pericyte-based vessel stabilization. Exogenous bone marrow derived-putative endothelial progenitor cells (b-pEPCs) have the potential for vascular repair; however, their effect on vascular structure stabilization and pericyte-related pathobiological outcomes in the injured kidney has not been fully examined.

Verified
Journal Article
Open access
PDF file
ZHZhizhi Hu
Zhizhi Hu
GPGuangchang Pei
Guangchang Pei
PWPengge Wang
Pengge Wang
JYJuan Yang
Juan Yang
FZFengming Zhu
Fengming Zhu
GXGang Xu
Gang Xu
Biliverdin reductase A is an enzyme, with serine/threonine/tyrosine kinase activation, converting biliverdin (BV) to bilirubin (BR) in heme degradation pathway. It has been reported to have anti-inflammatory and antioxidant effect in monocytes and human glioblastoma. However, the function of BVRA in polarized macrophage was unknown. This study aimed to investigate the effect of BVRA on macrophage activation and polarization in injured renal microenvironment. Classically activated macrophages (M1macrophages) and alternative activation of macrophages (M2 macrophages) polarization of murine bone marrow derived macrophage was induced by GM-CSF and M-CSF. M1 polarization was associated with a significant down-regulation of BVRA and Interleukin-10 (IL-10), and increased secretion of TNF-α. We also found IL-10 expression was increased in BVRA over-expressed macrophages, while it decreased in BVRA knockdown macrophages. In contrast, BVRA over-expressed or knockdown macrophages had no effect on TNF-α expression level, indicating BVRA mediated IL-10 expression in macrophages. Furthermore, we observed in macrophages infected with recombinant adenoviruses BVRA gene, which BVRA over-expressed enhanced both INOS and ARG-1 mRNA expression, resulting in a specific macrophage phenotype. Through in vivo study, we found BVRA positive macrophages largely existed in mice renal ischemia perfusion injury. With the treatment of the regular cytokines GM-CSF, M-CSF or LPS, excreted in the injured renal microenvironment, IL-10 secretion was significantly increased in BVRA over-expressed macrophages. In conclusion, the BVRA positive macrophage is a source of anti-inflammatory cytokine IL-10 in injured kidney, which may provide a potential target for treatment of kidney disease.

8 May 2024 in Medicina
Verified
Journal Article
Open access
PDF file
HXHuzi Xu
Huzi Xu
XWXiuru Wang
Xiuru Wang
FZFan Zhu
Fan Zhu
SGShuiming Guo
Shuiming Guo
ZCZheng Chao
Zheng Chao
YYYing Yao
Ying Yao
Background and Objectives: Connexin 43 (Cx43) is involved in the transfer of small signaling molecules between neighboring cells, thereby exerting a major influence on the initiation and progression of tumorigenesis. However, there is a lack of systematic research on Cx43 expression and its predictive role in clinical diagnosis and prognosis in pan-cancer. Materials and Methods: Several biological databases were used to evaluate the expression levels of GJA1 (encoding Cx43) and its diagnostic and prognostic significance in pan-cancer. We targeted kidney renal clear cell carcinoma (KIRC) and investigated the relationship between GJA1 expression and different clinical features of KIRC patients. Then, we performed cell-based experiments to partially confirm our results and predicted several proteins that were functionally related to Cx43. Results: The expression of GJA1 has a high level of accuracy in predicting KIRC. High GJA1 expression was remarkably correlated with a favorable prognosis, and this expression was reduced in groups with poor clinical features in KIRC. Cell experiments confirmed the inhibitory effects of increased GJA1 expression on the migratory capacity of human renal cancer (RCC) cell lines, and protein–protein interaction (PPI) analysis predicted that CDH1 and CTNNB1 were closely related to Cx43. Conclusions: GJA1 could be a promising independent favorable prognostic factor for KIRC, and upregulation of GJA1 expression could inhibit the migratory capacity of renal cancer cells.

26 September 2025 in Clinical Case Reports
Verified
Journal Article
Open access
MZMeng Zhang
Meng Zhang
YGYanchao Guo
Yanchao Guo
YZYan Zhu
Yan Zhu
JYJuan Yang
Juan Yang
Anemia is the most common complication of end‐stage renal disease (ESRD). While erythropoiesis‐stimulating agents (ESA) have improved treatment outcomes, some patients exhibit intolerance or hyporesponsiveness. Roxadustat, a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHI), improves erythropoiesis and iron metabolism, offering advantages in ESA‐refractory cases. However, its use in pediatric populations remains limited. We present a case of a 13‐year‐old girl on maintenance hemodialysis who exhibited both hyporesponsiveness and intolerance to ESA. Initiation of oral Roxadustat resulted in a sustained improvement in hemoglobin levels, accompanied by notable enhancements in iron metabolism and clinical symptoms. So far, over 5 years of follow‐up, no significant adverse events were observed. Oral Roxadustat appears to be an effective and safe treatment option for teenage hemodialysis patients who are resistant or intolerant to ESA.

1 April 2025 in IDCases
Verified
Journal Article
Open access
LMLi-Yan Mao
Li-Yan Mao
YTYi Tang
Yi Tang
JYJuan Yang
Juan Yang
Peritoneal dialysis-associated peritonitis is a leading cause of treatment discontinuation and mortality among peritoneal dialysis patients. The presence of multidrug-resistant organisms further complicates management, particularly in patients with complex intra-abdominal conditions. This paper presents a complicated case of refractory multidrug-resistant peritoneal dialysis-associated peritonitis, which was ultimately diagnosed as being caused by a teratoma. Following adequate drainage and the administration of sensitive antibiotics, the patient successfully underwent teratoma excision and transitioned to hemodialysis.